These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8650244)

  • 81. EFA (9-beta-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine.
    Batova A; Cottam H; Yu J; Diccianni MB; Carrera CJ; Yu AL
    Blood; 2006 Feb; 107(3):898-903. PubMed ID: 16234352
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Defects in methylthioadenosine phosphorylase are associated with but not responsible for methionine-dependent tumor cell growth.
    Tang B; Li YN; Kruger WD
    Cancer Res; 2000 Oct; 60(19):5543-7. PubMed ID: 11034100
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Mice heterozygous for germ-line mutations in methylthioadenosine phosphorylase (MTAP) die prematurely of T-cell lymphoma.
    Kadariya Y; Yin B; Tang B; Shinton SA; Quinlivan EP; Hua X; Klein-Szanto A; Al-Saleem TI; Bassing CH; Hardy RR; Kruger WD
    Cancer Res; 2009 Jul; 69(14):5961-9. PubMed ID: 19567676
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers.
    Nobori T; Miura K; Wu DJ; Lois A; Takabayashi K; Carson DA
    Nature; 1994 Apr; 368(6473):753-6. PubMed ID: 8152487
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Assignment of the gene for methylthioadenosine phosphorylase to human chromosome 9 by mouse-human somatic cell hybridization.
    Carrera CJ; Eddy RL; Shows TB; Carson DA
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2665-8. PubMed ID: 6425836
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Primate genome gain and loss: a bone dysplasia, muscular dystrophy, and bone cancer syndrome resulting from mutated retroviral-derived MTAP transcripts.
    Camacho-Vanegas O; Camacho SC; Till J; Miranda-Lorenzo I; Terzo E; Ramirez MC; Schramm V; Cordovano G; Watts G; Mehta S; Kimonis V; Hoch B; Philibert KD; Raabe CA; Bishop DF; Glucksman MJ; Martignetti JA
    Am J Hum Genet; 2012 Apr; 90(4):614-27. PubMed ID: 22464254
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines.
    Siebert R; Willers CP; Schramm A; Fosså A; Dresen IM; Uppenkamp M; Nowrousian MR; Seeber S; Opalka B
    Br J Haematol; 1995 Oct; 91(2):350-4. PubMed ID: 8547074
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin.
    Bataille F; Rogler G; Modes K; Poser I; Schuierer M; Dietmaier W; Ruemmele P; Mühlbauer M; Wallner S; Hellerbrand C; Bosserhoff AK
    Lab Invest; 2005 Jan; 85(1):124-36. PubMed ID: 15492751
    [TBL] [Abstract][Full Text] [Related]  

  • 89. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.
    Kryukov GV; Wilson FH; Ruth JR; Paulk J; Tsherniak A; Marlow SE; Vazquez F; Weir BA; Fitzgerald ME; Tanaka M; Bielski CM; Scott JM; Dennis C; Cowley GS; Boehm JS; Root DE; Golub TR; Clish CB; Bradner JE; Hahn WC; Garraway LA
    Science; 2016 Mar; 351(6278):1214-8. PubMed ID: 26912360
    [TBL] [Abstract][Full Text] [Related]  

  • 90. MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting
    Hu Q; Qin Y; Ji S; Shi X; Dai W; Fan G; Li S; Xu W; Liu W; Liu M; Zhang Z; Ye Z; Zhou Z; Yang J; Zhuo Q; Yu X; Li M; Xu X
    Cancer Res; 2021 Oct; 81(19):4964-4980. PubMed ID: 34385182
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers.
    Ngoi NYL; Tang TY; Gaspar CF; Pavlick DC; Buchold GM; Scholefield EL; Parimi V; Huang RSP; Janovitz T; Danziger N; Levy MA; Pant S; De Armas AD; Kumpula D; Ross JS; Javle M; Rodon Ahnert J
    Oncologist; 2024 Jun; 29(6):493-503. PubMed ID: 38330461
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine.
    Barekatain Y; Ackroyd JJ; Yan VC; Khadka S; Wang L; Chen KC; Poral AH; Tran T; Georgiou DK; Arthur K; Lin YH; Satani N; Ballato ES; Behr EI; deCarvalho AC; Verhaak RGW; de Groot J; Huse JT; Asara JM; Kalluri R; Muller FL
    Nat Commun; 2021 Jul; 12(1):4228. PubMed ID: 34244484
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Deficiency of 5'-deoxy-5'-methylthioadenosine phosphorylase activity in malignancy. Absence of the protein in human enzyme-deficient cell lines.
    Della Ragione F; Oliva A; Palumbo R; Russo GL; Gragnaniello V; Zappia V
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):533-8. PubMed ID: 1736901
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Polyamine Inhibitor SAM486A Augments Cytarabine Cytotoxicity in Methylthioadenosine Phosphorylase-deficient Leukemia Cells.
    Nishi R; Fujita K; Matsuda Y; Kamatani N; Yamauchi T
    Anticancer Res; 2024 Mar; 44(3):981-991. PubMed ID: 38423659
    [TBL] [Abstract][Full Text] [Related]  

  • 95. PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach.
    Barbarino M; Cesari D; Bottaro M; Luzzi L; Namagerdi A; Bertolino FM; Bellan C; Proietti F; Somma P; Micheli M; de Santi MM; Guazzo R; Mutti L; Pirtoli L; Paladini P; Indovina P; Giordano A
    J Cell Mol Med; 2020 May; 24(10):5565-5577. PubMed ID: 32301278
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Combined inhibition of MTAP and MAT2a mimics synthetic lethality in tumor models via PRMT5 inhibition.
    Bedard GT; Gilaj N; Peregrina K; Brew I; Tosti E; Shaffer K; Tyler PC; Edelmann W; Augenlicht LH; Schramm VL
    J Biol Chem; 2024 Jan; 300(1):105492. PubMed ID: 38000655
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Biochemical genetic analysis of the role of methylthioadenosine phosphorylase in a murine lymphoid cell line.
    Kubota M; Kamatani N; Carson DA
    J Biol Chem; 1983 Jun; 258(12):7288-91. PubMed ID: 6408072
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (
    Bou Zerdan M; Ashok Kumar P; Haroun E; Srivastava N; Ross J; Sivapiragasam A
    Oncotarget; 2023 Mar; 14():178-187. PubMed ID: 36913304
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance.
    Gjuka D; Adib E; Garrison K; Chen J; Zhang Y; Li W; Boutz D; Lamb C; Tanno Y; Nassar A; El Zarif T; Kale N; Rakaee M; Mouhieddine TH; Alaiwi SA; Gusev A; Rogers T; Gao J; Georgiou G; Kwiatkowski DJ; Stone E
    Cancer Cell; 2023 Oct; 41(10):1774-1787.e9. PubMed ID: 37774699
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma.
    Sommer J; Itani DM; Homlar KC; Keedy VL; Halpern JL; Holt GE; Schwartz HS; Coffin CM; Kelley MJ; Cates JM
    J Pathol; 2010 Apr; 220(5):608-17. PubMed ID: 20140939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.